Keyphrases
Specific Loss Power
100%
Liver-specific
100%
Lipolysis-stimulated Lipoprotein Receptor
100%
Type 2 Diabetes Mellitus (T2DM)
60%
Hepatic Lipid
40%
Triglycerides
40%
Metabolic Syndrome
40%
Dyslipidemia
40%
Hypertriglyceridemia
40%
Diabetes Distress
40%
Lipid Transporter
40%
Imitation
20%
Molecular Mechanism
20%
Diabetes
20%
Obesity
20%
Risk Factors
20%
Dysregulation
20%
Gain-of-function
20%
Expression Pattern
20%
Mouse Model
20%
Serum Levels
20%
Lipids
20%
Receptor Expression
20%
Knockdown
20%
Apolipoprotein E
20%
Lipid Receptors
20%
Alternative Treatment Strategies
20%
Differentially Expressed
20%
Cardiovascular Complications
20%
Energy Homeostasis
20%
ApoE KO Mice
20%
Type 2 Diabetic
20%
Hepatic Expression
20%
Lipid Handling
20%
Serum Triglycerides
20%
Metabolic Types
20%
Lipoprotein Receptors
20%
Leptin Replacement
20%
Serum Profile
20%
Hepatic Lipolysis
20%
Genetic Restoration
20%
Apolipoprotein B (Apo B)
20%
Biochemistry, Genetics and Molecular Biology
Lipolysis
100%
Hyperlipidemia
100%
Lipoprotein
100%
Lipid
33%
Wild Type
33%
Triglyceride
33%
Lipid Liver Level
33%
Dyslipidemia
33%
Hypertriglyceridemia
33%
Genetics
16%
Animal Model
16%
Mouse Model
16%
Homeostasis
16%
Blood Level
16%
Triacylglycerol Level
16%
Triacylglycerol Blood Level
16%
Apolipoprotein E Knockout Mouse
16%
Apolipoprotein B
16%
Apolipoprotein E
16%
Leptin
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hyperlipidemia
100%
Lipoprotein Receptor
100%
Triacylglycerol
50%
Maturity Onset Diabetes of the Young
50%
Metabolic Syndrome X
33%
Dyslipidemia
33%
Hypertriglyceridemia
33%
Mouse Model
16%
Apolipoprotein E Knockout Mouse
16%
Receptor
16%
Diabetes Mellitus
16%
Leptin
16%
Apolipoprotein B
16%
Apolipoprotein E
16%
Cardiovascular Disease
16%